Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-19-004583
Filing Date
2019-04-18
Accepted
2019-04-18 16:31:35
Documents
1
Period of Report
2018-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3476
  Complete submission text file 0001654954-19-004583.txt   5215
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O NEPHROGENEX, INC. 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address
Mitchum James P. (Reporting) CIK: 0001597439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34600 | Film No.: 19756274